Introduction
History
Interest in pancreatic hormones began at the turn of the 20th century. In 1902, Bayliss and Starling discover a pancreatic secretin involved in regulation of water homeostasis, giving rise to interest in pancreatic hormones. Shortly after, in 1906, Moore et al. hypothesize involvement of gastrointestinal hormone extracts in maintenance of the endocrine pancreas. Jean La Barre purifies glucose-lowering gut extracts in 1929 and characterizes them as incretins, which is short for intestine secretion insulin. Finally, in 1984, gastric inhibitory peptide (GIP) is isolated from porcupine intestine. Although GIP was initially characterized for its gastric inhibitory effects (hence the name), it was also shown that the polypeptide played an integral role in insulin signaling and secretion. Interestingly, it was found that the effect of GIP on insulin levels was still seen in its absence, hinting toward the presence of an additional incretin, which has now been classified as glucagon-like peptide-1 (GLP-1).
Biological Role
Figure 1. The biological roles of GIP and and GLP-1, incretin hormones.
The GIP receptor (GIPR) helps facilitate the transport of glucose into/out of the cell through the stimulation of insulin secretion.
[1]. GIPR is a type of
G-Protein Coupled Receptor (GPCR), and its natural ligand, GIP, serves as an initiator of a cellular signaling cascade, thereby activating adenylyl cyclase and increasing cAMP levels. Subsequently, insulin secretion is stimulated.
Insulin, a peptide hormone, is secreted by the pancreas in response to glucose ingestion, allowing intake of glucose into the cell via the
Glut2 transporter. In individuals with
diabetes, insulin is under-secreted or unresponsive to elevated glucose levels, raising blood glucose levels and resulting in failed glucose transport.
General Structure
appears as a typical G-Protein Coupled Receptor, containing a transmembrane domain with seven helical passes and an extracellular domain, where the ligand binds, these two domains comprise the . Intracellularly, the receptor is bound to a G-Protein which is comprised by the , , and subunits, where the Beta and Gamma subunits typically dimerize. Upon binding of GIP to the receptor, the intracellular signaling cascade is initiated.
Glucose-dependent Insulinotropic Polypeptide
Active Site
Associated Diseases
Medical Relevance
Tirzepatide
Figure 2. Sequence alignment of GLP-1, GIP, and Tirzepatide. Residues shown in black are found in all three amino acid sequences. Pink or red coloration denotes residues that are unique to GIP or GLP-1, respectively. The sequence of tirzepatide is colored accordingly, and residues differing from both GIP and GLP-1 are highlighted in blue. Residues that differ across all three structures are boxed.
